RegulatoryCompany release

Bioxytran's A-SUQAR supplement gets Free Sale Certificate, opening path to UAE registration

🇺🇸 Bioxytran, Inc (BIXT) · Thu 05 Nov 2026

The US firm says its pre-meal chewable tablet now has a legalised government certificate, and it plans to begin UAE registration with its distribution partner.

Bioxytran, Inc announced on 4 November 2026 that its A-SUQAR chewable tablet has received a government-issued Free Sale Certificate. The product is a dietary supplement taken before meals, intended to blunt post-meal blood sugar spikes.

According to the company, the certificate has been legalised by the Ministry of Foreign Affairs of the issuing country and prepared for attestation for use in the United Arab Emirates. The source summary does not name the issuing authority or the country involved.

Bioxytran and its distribution partner plan to start product registration in the UAE. They also intend to assess regulatory pathways in Saudi Arabia, Kuwait and other Gulf Cooperation Council (GCC) markets. The company says launch timing will depend on local regulatory requirements.

For context, a Free Sale Certificate is a document commonly requested by importing countries to show that a product may be freely sold in its country of origin. It is typically one part of a wider registration dossier rather than an approval in itself.

What it means for your team

  • A Free Sale Certificate is a supporting document, not a market authorisation. UAE registration still has to be completed, and the company ties launch timing to local requirements.
  • Regulatory teams planning GCC entry for supplements should check each market's rules on legalisation and attestation of origin-country documents, as these steps can affect timelines.
  • Bioxytran has only said it will assess Saudi Arabia, Kuwait and other GCC pathways. No filings or dates in those markets have been announced.

Company's press release (SEC filing): Bioxytran, Inc ↗

Article written by VigiEye from the official source (Bioxytran, Inc). Claims are the company's own. AI-assisted; check the source before acting.

More Regulatory All →